The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 30, 2021
Filed:
Aug. 18, 2016
Applicant:
Korea Institute of Radiological & Medical Sciences, Seoul, KR;
Inventors:
Kee Ho Lee, Seoul, KR;
Yang Hyun Kim, Seoul, KR;
Eun Ran Park, Seoul, KR;
Sung Sub Kim, Daejeon, KR;
Hyun Jin Shin, Seoul, KR;
Eun Ju Lee, Seoul, KR;
Chun Ho Kim, Seoul, KR;
Sang Jun Park, Seoul, KR;
Mi-yeun Kim, Incheon, KR;
Jie Young Song, Seoul, KR;
Assignee:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); G01N 33/50 (2006.01); A61K 31/713 (2006.01); C12N 15/113 (2010.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
G01N 33/5008 (2013.01); A61K 31/713 (2013.01); C12N 15/113 (2013.01); C12Q 1/6883 (2013.01); G01N 33/5023 (2013.01); C12N 2310/14 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01);
Abstract
Melanophilin (MLPH) of the present invention is involved in differentiation into an adipocyte or fat accumulation, and accordingly, obesity can be treated or prevented by inhibiting the MLPH. Further, by measuring an expression level of the MLPH, obesity can be diagnosed and treated, and therapeutic agents for obesity and agents regulating differentiation into adipocytes can be screened.